TY - JOUR
T1 - The ahmed baerveldt comparison study
T2 - Methodology, baseline patient characteristics, and intraoperative complications
AU - Barton, Keith
AU - Gedde, Steven J.
AU - Budenz, Donald L.
AU - Feuer, William J.
AU - Schiffman, Joyce
N1 - Copyright:
Copyright 2011 Elsevier B.V., All rights reserved.
PY - 2011/3
Y1 - 2011/3
N2 - Purpose The Ahmed Baerveldt Comparison (ABC) Study compares the long-term outcomes and complications of the Ahmed glaucoma valve (AGV; model FP7; New World Medical, Los Ranchos, CA) and the Baerveldt glaucoma implant (BGI; model 101-350; Abbott Medical Optics, Abbott Park, IL). Design Multicenter, randomized, controlled clinical trial. Participants Two hundred seventy-six glaucoma patients at 16 clinical centers worldwide who were 18 to 85 years of age with inadequately controlled intraocular pressure (IOP; <18 mmHg) in whom placement of an aqueous shunt was planned. Methods Study patients were randomized to undergo implantation of an AGV or a BGI. Main Outcome Measures Failure, defined as IOP >21 mmHg or not reduced by 20% less than baseline or IOP ≤5 mmHg (2 consecutive visits after 3 months), additional glaucoma surgery, removal of the implant, or loss of light perception vision. Results A total of 276 patients were enrolled between October 2006 and April 2008, including 143 in the AGV group and 133 in the BGI group. The mean age±standard deviation (SD) of patients enrolled was 63±14 years, and 52% were male. The mean baseline IOP±SD was 31.5±11.8 mmHg. Except for a 13% higher prevalence of hypertension in the AGV group, no significant differences in baseline demographic or ocular characteristics were observed between the study groups. Intraoperative complications occurred in 11 (8%) patients in the AGV group and in 16 (12%) patients in the BGI group (P = 0.31). Conclusions The ABC Study should yield valuable prospective data comparing 2 commonly used aqueous shunts in clinical practice. Financial Disclosure(s) Proprietary or commercial disclosure may be found after the references.
AB - Purpose The Ahmed Baerveldt Comparison (ABC) Study compares the long-term outcomes and complications of the Ahmed glaucoma valve (AGV; model FP7; New World Medical, Los Ranchos, CA) and the Baerveldt glaucoma implant (BGI; model 101-350; Abbott Medical Optics, Abbott Park, IL). Design Multicenter, randomized, controlled clinical trial. Participants Two hundred seventy-six glaucoma patients at 16 clinical centers worldwide who were 18 to 85 years of age with inadequately controlled intraocular pressure (IOP; <18 mmHg) in whom placement of an aqueous shunt was planned. Methods Study patients were randomized to undergo implantation of an AGV or a BGI. Main Outcome Measures Failure, defined as IOP >21 mmHg or not reduced by 20% less than baseline or IOP ≤5 mmHg (2 consecutive visits after 3 months), additional glaucoma surgery, removal of the implant, or loss of light perception vision. Results A total of 276 patients were enrolled between October 2006 and April 2008, including 143 in the AGV group and 133 in the BGI group. The mean age±standard deviation (SD) of patients enrolled was 63±14 years, and 52% were male. The mean baseline IOP±SD was 31.5±11.8 mmHg. Except for a 13% higher prevalence of hypertension in the AGV group, no significant differences in baseline demographic or ocular characteristics were observed between the study groups. Intraoperative complications occurred in 11 (8%) patients in the AGV group and in 16 (12%) patients in the BGI group (P = 0.31). Conclusions The ABC Study should yield valuable prospective data comparing 2 commonly used aqueous shunts in clinical practice. Financial Disclosure(s) Proprietary or commercial disclosure may be found after the references.
UR - http://www.scopus.com/inward/record.url?scp=79952280669&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79952280669&partnerID=8YFLogxK
U2 - 10.1016/j.ophtha.2010.07.015
DO - 10.1016/j.ophtha.2010.07.015
M3 - Article
C2 - 20932581
AN - SCOPUS:79952280669
VL - 118
SP - 435
EP - 442
JO - Ophthalmology
JF - Ophthalmology
SN - 0161-6420
IS - 3
ER -